12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Quantitative analysis of insulin in total parenteral nutrition bag in Taiwan

      research-article
      a , b , * , , c , b , c , * ,
      Journal of Food and Drug Analysis
      Taiwan Food and Drug Administration
      adsorption insulin total parenteral nutrition bags

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Regular insulin can reduce hyperglycemia when directly added to total parenteral nutrition (TPN) solutions. Insulin is not routinely added to all TPN solutions. For patients who require insulin prior to the initiation of TPN supplement, one-third to one-half of the usual total daily dose can be added to the TPN bag as regular human insulin. However, an incorrect dose or an interaction between insulin and the TPN bag material may affect blood sugar control in clinical practice. Therefore, it is important to quantitatively determine the final dose of insulin in the TPN bag. High performance liquid chromatography is a very powerful technique for determining the purity of proteins. The goal of this study was to use high-performance liquid chromatography to perform quantitative analysis of insulin in a TPN bag. The analysis was performed under different light conditions (UV, fluorescent, and darkness) and different temperatures (25°C and 2–8°C). The results show that adsorption of insulin on an ethylene vinyl acetate TPN bag is significantly higher than that on glass. Based on the results, it is evident that regular insulin should be administered separately from TPN to reduce cost and eliminate wasteful disposal of TPN solutions.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition.

          Hyperglycemia is associated with poor clinical outcomes and mortality in myocardial infarction, stroke, and general hospital patients. However, there are few data regarding the effect of hyperglycemia on outcomes in patients receiving total parenteral nutrition (TPN), a therapy that predisposes patients to hyperglycemia. The aim of this study was to determine whether elevated blood glucose levels are associated with adverse outcomes in patients receiving TPN. A retrospective analysis was undertaken from the medical records of 111 patients (122 treatment episodes) receiving TPN. All patients had blood drawn daily for the measurement of blood glucose levels. Outcome measures were assessed as a function of mean daily blood glucose levels while receiving TPN. Increased blood glucose levels were associated with an increased risk of cardiac complications (odds ratio 1.61, 95% CI 1.09-2.37, P = 0.02), infection (1.4, 1.08-1.82, P = 0.01), systemic sepsis (1.36, 1.00-1.86, P = 0.05), acute renal failure (1.47, 1.00-2.17, P = 0.05), and death (1.77, 1.23-2.52, P < 0.01). When the data were examined by quartiles of blood glucose levels, the mortality of subjects in the highest quartile was 10.9 times (95% CI 2.0-60.5, P < 0.01) that of subjects in the lowest quartile, and the risk of developing any complication was 4.3 times higher (1.4-13.1, P < 0.01). These effects were independent of age, sex, or prior diabetes status. Hyperglycemia is a predictor of poor outcomes in patients receiving TPN. The confirmation of a relation between blood glucose levels and adverse outcomes provides support for tight glycemic control in these patients.
            • Record: found
            • Abstract: not found
            • Article: not found

            Long-term total parenteral nutrition with growth, development, and positive nitrogen balance.

              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Parenteral Nutrition–Associated Hyperglycemia in Non–Critically Ill Inpatients Increases the Risk of In-Hospital Mortality (Multicenter Study)

              OBJECTIVE Hyperglycemia may increase mortality in patients who receive total parenteral nutrition (TPN). However, this has not been well studied in noncritically ill patients (i.e., patients in the nonintensive care unit setting). The aim of this study was to determine whether mean blood glucose level during TPN infusion is associated with increased mortality in noncritically ill hospitalized patients. RESEARCH DESIGN AND METHODS This prospective multicenter study involved 19 Spanish hospitals. Noncritically ill patients who were prescribed TPN were included prospectively, and data were collected on demographic, clinical, and laboratory variables as well as on in-hospital mortality. RESULTS The study included 605 patients (mean age 63.2 ± 15.7 years). The daily mean TPN values were 1.630 ± 323 kcal, 3.2 ± 0.7 g carbohydrates/kg, 1.26 ± 0.3 g amino acids/kg, and 0.9 ± 0.2 g lipids/kg. Multiple logistic regression analysis showed that the patients who had mean blood glucose levels >180 mg/dL during the TPN infusion had a risk of mortality that was 5.6 times greater than those with mean blood glucose levels 180 mg/dL) in noncritically ill patients who receive TPN is associated with a higher risk of in-hospital mortality.

                Author and article information

                Journal
                J Food Drug Anal
                J Food Drug Anal
                Journal of Food and Drug Analysis
                Taiwan Food and Drug Administration
                1021-9498
                2224-6614
                2016
                16 October 2015
                : 24
                : 1
                : 214-219
                Affiliations
                [a ]Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan
                [b ]Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
                [c ]School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan
                Author notes
                [* ]Corresponding authors. Department of Pharmacy, Kaohsiung Medical University Hospital, Number 100, Shihcyuan 1st Road, Sanmin District, Kaohsiung City 80708, Taiwan. E-mail addresses: 880032@ 123456gmail.com (H.-L. Tsao), jk2975525@ 123456hotmail.com (C.-Y. Chen).
                [1]

                Kuo-Hua Yu and Shun-Jin Lin contributed equally to this study.

                Article
                jfda-24-01-214
                10.1016/j.jfda.2015.08.003
                9345436
                28911406
                c8e9255e-cb0e-47b0-b4ad-0c9f4b08db59
                © 2016 Taiwan Food and Drug Administration

                This is an open access article under the CC-BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 23 May 2015
                : 08 July 2015
                : 14 August 2015
                Funding
                Funded by: Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
                Award ID: 93-ND-040
                Funded by: Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
                Award ID: KMUH103-3R69
                This study was supported by a grant from the Kaohsiung Medical University Hospital, Kaohsiung, Taiwan (93-ND-040) and by Kaohsiung Medical University Hospital, Kaohsiung, Taiwan (KMUH103-3R69).
                Categories
                Original Article

                adsorption insulin total parenteral nutrition bags

                Comments

                Comment on this article

                Related Documents Log